Distribution of TAS2R38 bitter taste receptor phenotype and haplotypes among COVID-19 patients

Abstract Bitter taste receptor TAS2R38 is expressed in the respiratory tract and can respond to quorum-sensing molecules produced by pathogens, stimulating the release of nitric oxide, with biocidal activity. TAS2R38 presents two main high-frequency haplotypes: the “taster” PAV and the “non-taster”...

Full description

Bibliographic Details
Main Authors: D. Risso, D. Carmagnola, G. Morini, G. Pellegrini, E. Canciani, M. Antinucci, D. Henin, C. Dellavia
Format: Article
Language:English
Published: Nature Portfolio 2022-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-10747-2
_version_ 1811308226410446848
author D. Risso
D. Carmagnola
G. Morini
G. Pellegrini
E. Canciani
M. Antinucci
D. Henin
C. Dellavia
author_facet D. Risso
D. Carmagnola
G. Morini
G. Pellegrini
E. Canciani
M. Antinucci
D. Henin
C. Dellavia
author_sort D. Risso
collection DOAJ
description Abstract Bitter taste receptor TAS2R38 is expressed in the respiratory tract and can respond to quorum-sensing molecules produced by pathogens, stimulating the release of nitric oxide, with biocidal activity. TAS2R38 presents two main high-frequency haplotypes: the “taster” PAV and the “non-taster” AVI. Individuals carrying the AVI allele could be at greater risk of infections, including SARS-CoV-2. The aim of this study was to assess the frequency of PAV and AVI alleles in COVID-19 patients with severe or non-severe symptoms compared to healthy subjects to further corroborate, or not, the hypothesis that the PAV allele may act as a protecting factor towards SARS-CoV-2 infection while the AVI one may represent a risk factor. After careful selection, 54 individuals were included in the study and underwent genetic analysis and PROP phenotype assessment. Our investigation could not point out at a significant relationship between single nucleotide polymorphisms responsible for PROP bitterness and presence/severity of SARS-CoV-2 infection, as previous studies suggested. Our results uncouple the direct genetic contribution of rs10246939, rs1726866 and rs713598 on COVID-19, calling for caution when proposing a treatment based on TAS2R38 phenotypes.
first_indexed 2024-04-13T09:19:24Z
format Article
id doaj.art-ebafc68eb8db4492897e7bb00889fca3
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-13T09:19:24Z
publishDate 2022-05-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-ebafc68eb8db4492897e7bb00889fca32022-12-22T02:52:40ZengNature PortfolioScientific Reports2045-23222022-05-011211710.1038/s41598-022-10747-2Distribution of TAS2R38 bitter taste receptor phenotype and haplotypes among COVID-19 patientsD. Risso0D. Carmagnola1G. Morini2G. Pellegrini3E. Canciani4M. Antinucci5D. Henin6C. Dellavia7Tate & Lyle PLCDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di MilanoUniversity of Gastronomic ScienceasDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di MilanoDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di MilanoDepartment of Medicine and Life Sciences, Institute of Evolutionary Biology (UPF-CSIC), Universitat Pompeu FabraDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di MilanoDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di MilanoAbstract Bitter taste receptor TAS2R38 is expressed in the respiratory tract and can respond to quorum-sensing molecules produced by pathogens, stimulating the release of nitric oxide, with biocidal activity. TAS2R38 presents two main high-frequency haplotypes: the “taster” PAV and the “non-taster” AVI. Individuals carrying the AVI allele could be at greater risk of infections, including SARS-CoV-2. The aim of this study was to assess the frequency of PAV and AVI alleles in COVID-19 patients with severe or non-severe symptoms compared to healthy subjects to further corroborate, or not, the hypothesis that the PAV allele may act as a protecting factor towards SARS-CoV-2 infection while the AVI one may represent a risk factor. After careful selection, 54 individuals were included in the study and underwent genetic analysis and PROP phenotype assessment. Our investigation could not point out at a significant relationship between single nucleotide polymorphisms responsible for PROP bitterness and presence/severity of SARS-CoV-2 infection, as previous studies suggested. Our results uncouple the direct genetic contribution of rs10246939, rs1726866 and rs713598 on COVID-19, calling for caution when proposing a treatment based on TAS2R38 phenotypes.https://doi.org/10.1038/s41598-022-10747-2
spellingShingle D. Risso
D. Carmagnola
G. Morini
G. Pellegrini
E. Canciani
M. Antinucci
D. Henin
C. Dellavia
Distribution of TAS2R38 bitter taste receptor phenotype and haplotypes among COVID-19 patients
Scientific Reports
title Distribution of TAS2R38 bitter taste receptor phenotype and haplotypes among COVID-19 patients
title_full Distribution of TAS2R38 bitter taste receptor phenotype and haplotypes among COVID-19 patients
title_fullStr Distribution of TAS2R38 bitter taste receptor phenotype and haplotypes among COVID-19 patients
title_full_unstemmed Distribution of TAS2R38 bitter taste receptor phenotype and haplotypes among COVID-19 patients
title_short Distribution of TAS2R38 bitter taste receptor phenotype and haplotypes among COVID-19 patients
title_sort distribution of tas2r38 bitter taste receptor phenotype and haplotypes among covid 19 patients
url https://doi.org/10.1038/s41598-022-10747-2
work_keys_str_mv AT drisso distributionoftas2r38bittertastereceptorphenotypeandhaplotypesamongcovid19patients
AT dcarmagnola distributionoftas2r38bittertastereceptorphenotypeandhaplotypesamongcovid19patients
AT gmorini distributionoftas2r38bittertastereceptorphenotypeandhaplotypesamongcovid19patients
AT gpellegrini distributionoftas2r38bittertastereceptorphenotypeandhaplotypesamongcovid19patients
AT ecanciani distributionoftas2r38bittertastereceptorphenotypeandhaplotypesamongcovid19patients
AT mantinucci distributionoftas2r38bittertastereceptorphenotypeandhaplotypesamongcovid19patients
AT dhenin distributionoftas2r38bittertastereceptorphenotypeandhaplotypesamongcovid19patients
AT cdellavia distributionoftas2r38bittertastereceptorphenotypeandhaplotypesamongcovid19patients